{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T09:48:19Z","timestamp":1723715299934},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:00:00Z","timestamp":1711497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:00:00Z","timestamp":1711497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pregnant women might have an increased risk of SARS-COV-2 infection. Although evidence towards the efficacy and safety of COVID-19 is growing still there is room for improvement on the knowledge towards pregnancy adverse events, such as miscarriage. We explored the association of COVID-19 vaccine with the risk of miscarriages using the Real-World. We identified a cohort of vaccinated pregnancies using the BIFAP database which contains systematically recorded data on care patients in Spain (N\u2009=\u20094054). We then restricted it to those women who had a miscarriage using a validated algorithm (N\u2009=\u2009607). Among them, we performed a case-crossover design to evaluate the effect of intermittent exposures on the risk of miscarriage. Adjusted Odds Ratio with their confidence intervals were calculated using two analytical approaches: conditional logistic regression and Generalized Linear Mixed-Effects Models. A total of 225 (37.1%) were aged 35\u201339\u00a0years. The most common comorbidities were asthma, migraine, gastritis, and hypothyroidism. A total of 14.7% received only one dose of COVID-19 and 85.3% two doses, respectively. A total of 36.8% of women with one dose and 27.6% with two doses received the vaccine 7\u00a0days prior to the miscarriage. Corresponding adjusted estimates for the risk of miscarriage using the conditional logistic regression where as follows: 1.65 (95% CI 0.85\u20133.23) when using as the sum of 3 control moments among women with one dose, 1.02 (95% CI 0.72\u20131.46) among women with two doses and 1.03 (95% CI 0.72, 1.46) using the whole study population. Very similar results were obtained when conducting the Generalized Linear Mixed-Effects Models. There was no overall increased risk of miscarriage onset associated with COVID-19 vaccine although contradictory results were found according to the number of doses. Further studies are required with larger sample sizes to assess this association.<\/jats:p>","DOI":"10.1038\/s41598-024-57880-8","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T12:02:21Z","timestamp":1711540941000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lack of association between COVID-19 vaccines and miscarriage onset using a case-crossover design"],"prefix":"10.1038","volume":"14","author":[{"given":"Irati","family":"Gastesi Orbegozo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc\u00eda","family":"Cea-Soriano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Llorente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Consuelo","family":"Huerta-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,27]]},"reference":[{"key":"57880_CR1","unstructured":"MedlinePlus. Miscarriage (2014). https:\/\/medlineplus.gov\/ency\/article\/001488.htm"},{"issue":"2","key":"57880_CR2","doi-asserted-by":"publisher","first-page":"100107","DOI":"10.1016\/j.ajogmf.2020.100107","volume":"2","author":"D Di Mascio","year":"2020","unstructured":"Di Mascio, D. et al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: A systematic review and meta-analysis. Am. J. Obst. Gynecolo. MFM 2(2), 100107 (2020).","journal-title":"Am. J. Obst. Gynecolo. MFM"},{"issue":"16","key":"57880_CR3","doi-asserted-by":"publisher","first-page":"E540","DOI":"10.1503\/cmaj.202604","volume":"193","author":"SQ Wei","year":"2021","unstructured":"Wei, S. Q., Bilodeau-Bertrand, M., Liu, S. & Auger, N. The impact of COVID-19 on pregnancy outcomes: A systematic review and meta-analysis. CMAJ 193(16), E540\u2013E548 (2021).","journal-title":"CMAJ"},{"issue":"6","key":"57880_CR4","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.jinf.2020.03.041","volume":"80","author":"L Fu","year":"2020","unstructured":"Fu, L. et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis. J. Infect. 80(6), 656\u2013665 (2020).","journal-title":"J. Infect."},{"issue":"1","key":"57880_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-020-01798-1","volume":"18","author":"R Yang","year":"2020","unstructured":"Yang, R. et al. Pregnant women with COVID-19 and risk of adverse birth outcomes and maternal-fetal vertical transmission: A population-based cohort study in Wuhan, China. BMC Med. 18(1), 1\u20137 (2020).","journal-title":"BMC Med."},{"issue":"3","key":"57880_CR6","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1097\/AOG.0000000000004256","volume":"137","author":"M Gulersen","year":"2021","unstructured":"Gulersen, M. et al. Coronavirus disease 2019 (COVID-19)-related multisystem inflammatory syndrome in a pregnant woman. Obstet. Gynecol. 137(3), 418\u2013422 (2021).","journal-title":"Obstet. Gynecol."},{"issue":"11","key":"57880_CR7","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1097\/01.ogx.0000721400.07132.fc","volume":"75","author":"S Ellington","year":"2020","unstructured":"Ellington, S. et al. Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status-United States, January 22-June 7, 2020. Obstet. Gynecol. Surv. 75(11), 664\u2013666 (2020).","journal-title":"Obstet. Gynecol. Surv."},{"key":"57880_CR8","doi-asserted-by":"publisher","first-page":"100446","DOI":"10.1016\/j.eclinm.2020.100446","volume":"25","author":"A Khalil","year":"2020","unstructured":"Khalil, A. et al. SARS-CoV-2 infection in pregnancy: A systematic review and meta-analysis of clinical features and pregnancy outcomes. EClinicalMedicine 25, 100446 (2020).","journal-title":"EClinicalMedicine"},{"key":"57880_CR9","doi-asserted-by":"publisher","first-page":"106260","DOI":"10.1016\/j.ijantimicag.2020.106260","volume":"57","author":"Z He","year":"2021","unstructured":"He, Z. et al. Vertical transmission and kidney damage in newborns whose mothers had coronavirus disease 2019 during pregnancy. Int. J. Antimicrob. Agents 57, 106260 (2021).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"57880_CR10","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.jiph.2021.04.005","volume":"14","author":"R Kumar","year":"2021","unstructured":"Kumar, R. et al. SARS-CoV-2 infection during pregnancy and pregnancy-related conditions: Concerns, challenges, management and mitigation strategies\u2013a narrative review. J. Infect. Public Health 14, 863\u2013875 (2021).","journal-title":"J. Infect. Public Health"},{"key":"57880_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bpobgyn.2021.02.002","volume":"76","author":"MLR Arora","year":"2021","unstructured":"Arora, M. L. R. Vaccines: Safety in pregnancy. Best Prct. Res. Clin. Obs. Gynaecol. 76, 23\u201340 (2021).","journal-title":"Best Prct. Res. Clin. Obs. Gynaecol."},{"key":"57880_CR12","unstructured":"Centers for Disease Control and Prevention (CDC). COVID-19 Vaccines While Pregnant or Breastfeeding. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/recommendations\/pregnancy.html. Accessed 6 Aug 2021."},{"key":"57880_CR13","unstructured":"Monday, U. & Committee, J. Covid- C. What are the benefits of vaccination\u202f? What are the risks of vaccination\u202f? 2021;(December):1\u20136."},{"issue":"24","key":"57880_CR14","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1056\/NEJMoa2104983","volume":"384","author":"TT Shimabukuro","year":"2021","unstructured":"Shimabukuro, T. T. et al. Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. N. Engl. J. Med. 384(24), 2273\u20132282 (2021).","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"57880_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ajog.2021.08.054","volume":"226","author":"DJ Jamieson","year":"2022","unstructured":"Jamieson, D. J. & Rasmussen, S. A. An update on COVID-19 and pregnancy. Am. J. Obstet. Gynecol. 226(2), 177\u2013186 (2022).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"57880_CR16","unstructured":"Beutner, D., Klussmann, J. & Guntinas-lichius, O. C or R E Sp ondence, 1194\u20135 (2008)."},{"issue":"16","key":"57880_CR17","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1056\/NEJMc2112411","volume":"385","author":"M Packer","year":"2021","unstructured":"Packer, M. et al. Empagliflozin and major renal outcomes in heart failure. N. Engl. J. Med. 385(16), 1531\u20131533 (2021).","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"57880_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/pds.4910","volume":"29","author":"S Sanchez Ortiz","year":"2020","unstructured":"Sanchez Ortiz, S., Llorente Garc\u00eda, A., Astasio, P., Huerta, C. & Cea, S. L. An algorithm to identify pregnancies in BIFAP primary care database in Spain: Results from a cohort of 155 419 pregnancies. Pharmacoepidemiol. Drug Saf. 29(1), 57\u201368 (2020).","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"5","key":"57880_CR19","doi-asserted-by":"publisher","first-page":"596","DOI":"10.3390\/healthcare9050596","volume":"9","author":"SS Ortiz","year":"2021","unstructured":"Ortiz, S. S. et al. A validation study on the frequency and natural history of miscarriages using the Spanish primary care database BIFAP. Healthcare 9(5), 596 (2021).","journal-title":"Healthcare"},{"issue":"10","key":"57880_CR20","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/pds.5006","volume":"29","author":"MA Maci\u00e1-Mart\u00ednez","year":"2020","unstructured":"Maci\u00e1-Mart\u00ednez, M. A. et al. Base de datos para la investigaci\u00f3n farmacoepidemiol\u00f3gica en atenci\u00f3n primaria (BIFAP): A data resource for pharmacoepidemiology in Spain. Pharmacoepidemiol. Drug Saf. 29(10), 1236\u20131245 (2020).","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"11","key":"57880_CR21","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1093\/aje\/kwx105","volume":"185","author":"M Maclure","year":"2017","unstructured":"Maclure, M. The case-crossover design: A method for studying transient effects on the risk of acute events. Am. J. Epidemiol. 185(11), 1174\u20131183 (2017).","journal-title":"Am. J. Epidemiol."},{"key":"57880_CR22","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1146\/annurev.publhealth.21.1.193","volume":"21","author":"MMM Maclure","year":"2000","unstructured":"Maclure, M. M. M. Should we use a case-crossover design?. Annu. Rev. Public Health 21, 193\u2013221 (2000).","journal-title":"Annu. Rev. Public Health"},{"issue":"15\u201316","key":"57880_CR23","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1016\/j.vaccine.2004.01.017","volume":"22","author":"CP Farrington","year":"2004","unstructured":"Farrington, C. P. Control without separate controls: Evaluation of vaccine safety using case-only methods. Vaccine 22(15\u201316), 2064\u20132070 (2004).","journal-title":"Vaccine"},{"issue":"1","key":"57880_CR24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/oxfordjournals.aje.a117550","volume":"142","author":"MA Mittleman","year":"1995","unstructured":"Mittleman, M. A. & MalcolmMaclure, J. M. R. Control Sampling strategies for case-crossover studies: An assessment of relative efficiency. Am. J. Epidemiol. 142(1), 91\u201398 (1995).","journal-title":"Am. J. Epidemiol."},{"key":"57880_CR25","doi-asserted-by":"publisher","first-page":"e000214","DOI":"10.1136\/bmjmed-2022-000214","volume":"1","author":"D Lewer","year":"2021","unstructured":"Lewer, D. & Petersen, I. M. M. The case-crossover design for studying sudden events. BMJ Med. 1, e000214 (2021).","journal-title":"BMJ Med."},{"issue":"4","key":"57880_CR26","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/aje\/kwg144","volume":"158","author":"S Hern\u00e1ndez-D\u00edaz","year":"2003","unstructured":"Hern\u00e1ndez-D\u00edaz, S., Hern\u00e1n, M. A., Meyer, K., Werler, M. M. & Mitchell, M. A. Case-crossover and case-time-control designs in birth defects epidemiology. Am. J. Epidemiol. 158(4), 385\u2013391 (2003).","journal-title":"Am. J. Epidemiol."},{"issue":"08","key":"57880_CR27","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1055\/s-0040-1712103","volume":"37","author":"DD Smith","year":"2020","unstructured":"Smith, D. D. et al. Exclusion of pregnant women from clinical trials during the coronavirus disease 2019 pandemic: A review of international registries. Am. J. Perinatol. 37(08), 792\u2013799 (2020).","journal-title":"Am. J. Perinatol."},{"issue":"6","key":"57880_CR28","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.whi.2022.06.004","volume":"32","author":"KM Kons","year":"2022","unstructured":"Kons, K. M. et al. Exclusion of reproductive-aged women in COVID-19 vaccination and clinical trials. Women\u2019s Health Issues 32(6), 557\u2013563 (2022).","journal-title":"Women\u2019s Health Issues"},{"key":"57880_CR29","unstructured":"109 BioNTech SE. A phase 2\/3, placebo-controlled, randomized, observer-blind study to evaluate the safety, tolerability, and immunogenicity of a SARS-COV-2 RNA vaccine candidate (BNT162b2) against Covid-19 in healthy pregnant women 18 years of age and older. (2022). https:\/\/clinicaltrials.gov\/"},{"key":"57880_CR30","unstructured":"4594, B.V 110 Janssen Vaccines & Prevention. An open-label, phase 2 study to evaluate the safety, reactogenicity, and immunogenicity of Ad26.COV2.S in healthy pregnant participants. (2022). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT0475"},{"key":"57880_CR31","unstructured":"Ottawa Hospital Research I. Pregnant and Lactating Individuals & Newborns COVID-19 Vaccination Prospective Cohort Study. ClinicalTrials.gov [Internet] (2021). https:\/\/clinicaltrials.gov\/show\/NCT05115617"},{"key":"57880_CR32","unstructured":"Janssen Vaccines & Prevention B.V. A Study of Ad26.COV2.S in Healthy Pregnant Participants (COVID-19) (HORIZON 1). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04765384"},{"issue":"3","key":"57880_CR33","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1080\/21645515.2018.1540807","volume":"15","author":"ML Giles","year":"2019","unstructured":"Giles, M. L., Krishnaswamy, S., Macartney, K. & Cheng, A. The safety of inactivated influenza vaccines in pregnancy for birth outcomes: a systematic review. Hum Vaccin Immunother. 15(3), 687\u2013699 (2019).","journal-title":"Hum Vaccin Immunother."},{"issue":"44","key":"57880_CR34","doi-asserted-by":"publisher","first-page":"6553","DOI":"10.1016\/j.vaccine.2021.09.003","volume":"39","author":"CJ Romano","year":"2021","unstructured":"Romano, C. J. et al. History of pandemic H1N1-containing influenza vaccination and risk for spontaneous abortion and birth defects. Vaccine 39(44), 6553\u20136562 (2021).","journal-title":"Vaccine"},{"issue":"37","key":"57880_CR35","doi-asserted-by":"publisher","first-page":"4443","DOI":"10.1016\/j.vaccine.2016.06.054","volume":"34","author":"CD Chambers","year":"2016","unstructured":"Chambers, C. D. et al. Safety of the 2010-11, 2011-12, 2012-13, and 2013-14 seasonal influenza vaccines in pregnancy: Birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants, a study from the cohort arm of VAMPSS. Vaccine 34(37), 4443\u20134449 (2016).","journal-title":"Vaccine"},{"issue":"2","key":"57880_CR36","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1080\/21645515.2017.1403702","volume":"14","author":"LS Sy","year":"2018","unstructured":"Sy, L. S. et al. Postlicensure safety surveillance of congenital anomaly and miscarriage among pregnancies exposed to quadrivalent human papillomavirus vaccine. Hum. Vaccin. Immunother. 14(2), 412\u2013419 (2018).","journal-title":"Hum. Vaccin. Immunother."},{"issue":"2","key":"57880_CR37","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/AOG.0000000000004438","volume":"138","author":"M Prabhu","year":"2021","unstructured":"Prabhu, M. et al. Antibody response to coronavirus disease 2019 (COVID-19) messenger RNA vaccination in pregnant women and transplacental passage into cord blood. Obstet. Gynecol. 138(2), 278\u2013280 (2021).","journal-title":"Obstet. Gynecol."},{"issue":"21","key":"57880_CR38","first-page":"187","volume":"S0002\u20139378","author":"KJ Gray","year":"2021","unstructured":"Gray, K. J. et al. Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study. Am. J. Obstet. Gynecol. S0002\u20139378(21), 187\u2013193 (2021).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"57880_CR39","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ijid.2023.01.018","volume":"128","author":"S Wu","year":"2023","unstructured":"Wu, S. et al. The dose-and time-dependent effectiveness and safety associated with COVID-19 vaccination during pregnancy: A systematic review and meta-analysis. Int. J. Infect. Dis. 128, 335\u2013346 (2023).","journal-title":"Int. J. Infect. Dis."},{"key":"57880_CR40","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.11035","author":"I Goldshtein","year":"2021","unstructured":"Goldshtein, I. et al. As-sociation between BNT162b2 vaccination and incidence of SARS-CoV-2 infection in pregnant women. JAMA https:\/\/doi.org\/10.1001\/jama.2021.11035 (2021).","journal-title":"JAMA"},{"issue":"2","key":"57880_CR41","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/1471-0528.16941","volume":"129","author":"M Rottenstreich","year":"2022","unstructured":"Rottenstreich, M. et al. Covid-19 vaccination during the third trimester of pregnancy: Rate of vaccination and maternal and neonatal outcomes, a multicentre retrospective cohort study. BJOG 129(2), 248\u2013255 (2022).","journal-title":"BJOG"},{"key":"57880_CR42","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1056\/NEJMc2114466","volume":"385","author":"MC Magnus","year":"2021","unstructured":"Magnus, M. C., Gjessing, H. K., Eide, H. N., Wilcox, A. J. & Fell, D. B. H. S. Covid-19 vaccination during pregnancy and first-trimester miscarriage. N. Engl. J. Med. 385, 2008\u20132010 (2021).","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"57880_CR43","doi-asserted-by":"publisher","first-page":"100467","DOI":"10.1016\/j.ajogmf.2021.100467","volume":"3","author":"RN Theiler","year":"2021","unstructured":"Theiler, R. N. et al. Pregnancy and birth outcomes after SARS-CoV-2 vaccination in pregnancy. Am. J. Obst. Gynecol. MFM 3(6), 100467 (2021).","journal-title":"Am. J. Obst. Gynecol. MFM"},{"issue":"3","key":"57880_CR44","doi-asserted-by":"publisher","first-page":"e2434","DOI":"10.1002\/rmv.2434","volume":"33","author":"M Rahmati","year":"2023","unstructured":"Rahmati, M. et al. Effects of COVID-19 vaccination during pregnancy on SARS-CoV-2 infection and maternal and neonatal outcomes: A systematic review and meta-analysis. Rev. Med. Virol. 33(3), e2434 (2023).","journal-title":"Rev. Med. Virol."},{"issue":"3","key":"57880_CR45","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3390\/v14030539","volume":"14","author":"DU De Rose","year":"2022","unstructured":"De Rose, D. U., Salvatori, G., Dotta, A. & Auriti, C. SARS-CoV-2 vaccines during pregnancy and breastfeeding: A systematic review of maternal and neonatal outcomes. Viruses 14(3), 539 (2022).","journal-title":"Viruses"},{"issue":"1","key":"57880_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-022-30052-w","volume":"13","author":"S Prasad","year":"2022","unstructured":"Prasad, S. et al. Systematic review and meta-analysis of the effectiveness and perinatal outcomes of COVID-19 vaccination in pregnancy. Nat. Commun. 13(1), 1\u20138 (2022).","journal-title":"Nat. Commun."},{"issue":"24","key":"57880_CR47","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1056\/NEJMoa2104983","volume":"384","author":"TT Shimabukuro","year":"2021","unstructured":"Shimabukuro, T. T. et al. Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. N. Engl. J. Med. 384(24), 2273\u20132282 (2021).","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"57880_CR48","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1093\/humrep\/dead036","volume":"38","author":"MP Rimmer","year":"2023","unstructured":"Rimmer, M. P., Teh, J. J., Mackenzie, S. C. & Al Wattar, B. H. The risk of miscarriage following COVID-19 vaccination: A systematic review and meta-analysis. Hum. Reprod. 38(5), 840\u2013852 (2023).","journal-title":"Hum. Reprod."},{"key":"57880_CR49","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1007\/s11845-021-02807-9","volume":"191","author":"L Schaler","year":"2022","unstructured":"Schaler, L. & Wingfield, M. COVID-19 vaccine: Can it affect fertility?. Ir. J. Med. Sci. 191, 2185\u20132187 (2022).","journal-title":"Ir. J. Med. Sci."},{"key":"57880_CR50","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1038\/s41423-021-00773-x","volume":"18","author":"M Prasad","year":"2021","unstructured":"Prasad, M. et al. No crossreactivity of anti-SARS-CoV-2 spike protein antibodies with Syncytin-1. Cell. Mol. Immunol. 18, 2566\u20132568 (2021).","journal-title":"Cell. Mol. Immunol."},{"issue":"2","key":"57880_CR51","doi-asserted-by":"publisher","first-page":"236.e1","DOI":"10.1016\/j.ajog.2021.08.007","volume":"226","author":"H Blakeway","year":"2022","unstructured":"Blakeway, H. et al. COVID-19 vaccination during pregnancy: Coverage and safety. Am. J. Obst. Gynecol. 226(2), 236.e1-236.e14 (2022).","journal-title":"Am. J. Obst. Gynecol."},{"key":"57880_CR52","doi-asserted-by":"publisher","first-page":"1054273","DOI":"10.3389\/fimmu.2022.1054273","volume":"13","author":"H Chen","year":"2023","unstructured":"Chen, H., Zhang, X., Lin, G. & Hocher, B. Safety of COVID-19 vaccination in women undergoing IVF\/ICSI treatment-Clinical study and systematic review. Front. Immunol. 13, 1054273 (2023).","journal-title":"Front. Immunol."},{"key":"57880_CR53","unstructured":"Atlanta, G. A. US Department of Health and Human Services C. COVID-19 vaccines while pregnant or breastfeeding (2021)."},{"issue":"2","key":"57880_CR54","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/ijgo.13713","volume":"154","author":"S Goncu Ayhan","year":"2021","unstructured":"Goncu Ayhan, S. et al. COVID-19 vaccine acceptance in pregnant women. Int. J. Gynecol. Obst. 154(2), 291\u2013296 (2021).","journal-title":"Int. J. Gynecol. Obst."},{"key":"57880_CR55","doi-asserted-by":"publisher","first-page":"101713","DOI":"10.1016\/j.pmedr.2022.101713","volume":"26","author":"KK Sznajder","year":"2022","unstructured":"Sznajder, K. K. et al. Covid-19 vaccine acceptance and associated factors among pregnant women in Pennsylvania 2020. Prev. Med. Rep. 26, 101713 (2022).","journal-title":"Prev. Med. Rep."},{"key":"57880_CR56","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/B978-0-444-51862-0.50018-6","volume":"7","author":"JKG Arijit Chakrabarti","year":"2011","unstructured":"Arijit Chakrabarti, J. K. G. AIC, BIC and recent advances in model selection. Philos. Stat. 7, 583\u2013605 (2011).","journal-title":"Philos. Stat."},{"key":"57880_CR57","unstructured":"Mart\u00ednez, D. R., Alb\u00edn, J. L., Cabaleiro, J. C., Pena, T. F., Rivera, F. F., Blanco, V. Criterio de informaci\u00f3n de {A}kaike en la obtenci\u00f3n de modelos estad\u00edsticos de Rendimiento. XX Jornadas Paralelismo, 439\u201344 (2009)."},{"key":"57880_CR58","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1214\/aos\/1176344136","volume":"6","author":"GE Schwarz","year":"1978","unstructured":"Schwarz, G. E. Estimating the dimension of a model. Ann. Stat. 6, 461\u2013464 (1978).","journal-title":"Ann. Stat."},{"key":"57880_CR59","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511790942","volume-title":"Data Analysis Using Regression And Multilevel\/Hierarchical Models","author":"A Gelman","year":"2006","unstructured":"Gelman, A. & Hill, J. Data Analysis Using Regression And Multilevel\/Hierarchical Models (Cambridge University Press, 2006)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-57880-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-57880-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-57880-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T13:06:00Z","timestamp":1711544760000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-57880-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,27]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["57880"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-57880-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,27]]},"assertion":[{"value":"6 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7275"}}